News

The latest GID BIO and cellular therapy news.

Wake Forest Medical School added as newest site in pivotal trial
Neil Sparks, DO, MS, a North Carolina physician specializing in the comprehensive primary and musculoskeletal care of children, adults and families, is the newest principal investigator in GID BIO's pivotal trial...
Read More
  • News
Orlando Medical News features GID BIO’s cellular therapy and pivotal clinical trial
Read More
  • Media
San Antonio Business Journal features GID BIO’s cellular therapy and pivotal clinical trial principal investigator, Dr. Jaime Garza: “On the forefront of new cell therapy research, an Alamo City surgeon has a key role in moving new medical technology to market”
Read More
  • Media
Late-stage biotech GID BIO wins funding from Richard King Mellon Foundation
LOUISVILLE, Colo. and PITTSBURGH, Aug. 18, 2020 -- Following FDA clearance of an expanded access protocol to treat a small group of COVID-19 patients using the GID BIO technology platform, The Richard King Mellon Foundation has awarded $250,000 to GID BIO to conduct the study for patients with severe respiratory distress due to COVID-19...
Read More
  • News
Denver Business Journal features GID BIO: “Colorado biotech firm’s new cell therapy could eliminate the need for knee replacements”
Read More
  • Media